These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16343666)

  • 21. Community-based study of atrial fibrillation and stroke prevention.
    White S; Feely J; O'Neill D
    Ir Med J; 2004 Jan; 97(1):10-2. PubMed ID: 15055913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.
    Garwood CL; Corbett TL
    Ann Pharmacother; 2008 Apr; 42(4):523-32. PubMed ID: 18334606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
    Hermosillo AJ; Spinler SA
    Ann Pharmacother; 2008 Jun; 42(6):790-805. PubMed ID: 18477734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves.
    Eikelboom JW; Hart RG
    Am J Hematol; 2012 May; 87 Suppl 1():S100-7. PubMed ID: 22389052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long term anticoagulation or antiplatelet treatment. Only warfarin has been shown to reduce stroke risk in patients with atrial fibrillation.
    Cleland JG; Kaye GC
    BMJ; 2001 Jul; 323(7306):233; author reply 235-6. PubMed ID: 11496885
    [No Abstract]   [Full Text] [Related]  

  • 26. Reducing the risk for stroke in patients who have atrial fibrillation.
    Garcia DA; Hylek E
    Cardiol Clin; 2008 May; 26(2):267-75, vii. PubMed ID: 18406999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of inappropriate use of digoxin in 136 patients on digoxin and prevalence of use of warfarin or aspirin in 89 patients with persistent or paroxysmal atrial fibrillation.
    Lleva P; Aronow WS; Gutwein AH
    Am J Ther; 2009; 16(6):e41-3. PubMed ID: 19940604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long term anticoagulation or antiplatelet treatment. Inclusion criteria determine results of review.
    Mant J; Fitzmaurice D; Murray E; Lip GY; Hobbs FD
    BMJ; 2001 Jul; 323(7306):233-4; author reply 235-6. PubMed ID: 11496884
    [No Abstract]   [Full Text] [Related]  

  • 29. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO).
    Rash A; Downes T; Portner R; Yeo WW; Morgan N; Channer KS
    Age Ageing; 2007 Mar; 36(2):151-6. PubMed ID: 17175564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A community-based educational intervention to improve antithrombotic drug use in atrial fibrillation.
    Jackson SL; Peterson GM; Vial JH
    Ann Pharmacother; 2004 Nov; 38(11):1794-9. PubMed ID: 15454583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of stroke in patients with atrial fibrillation.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
    [No Abstract]   [Full Text] [Related]  

  • 32. Long term anticoagulation or antiplatelet treatment. How do we decide between warfarin and aspirin?
    Cates C
    BMJ; 2001 Jul; 323(7306):235-6. PubMed ID: 11496890
    [No Abstract]   [Full Text] [Related]  

  • 33. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
    Maegdefessel L; Schlitt A; Faerber J; Bond SP; Messow CM; Buerke M; Raaz U; Werdan K; Muenzel T; Weiss C
    Med Klin (Munich); 2008 Sep; 103(9):628-32. PubMed ID: 18813885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reconsidering combined antiplatelet and anticoagulant therapy in atrial fibrillation.
    Falk RH
    J Am Coll Cardiol; 2004 Oct; 44(8):1567-9. PubMed ID: 15489086
    [No Abstract]   [Full Text] [Related]  

  • 35. Warfarin, aspirin, or both after myocardial infarction.
    Aronow WS
    N Engl J Med; 2003 Jan; 348(3):256-7; author reply 256-7. PubMed ID: 12530434
    [No Abstract]   [Full Text] [Related]  

  • 36. [Anticoagulation treatment in real-life practice of patient with nonvalvular atrial fibrillation in Beijing city].
    Zuo HJ; Su JL; Zeng H; Yuan BH; Yao CH
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2328-31. PubMed ID: 18036295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should hemodialysis patients with atrial fibrillation undergo systemic anticoagulation? A cost-utility analysis.
    Quinn RR; Naimark DM; Oliver MJ; Bayoumi AM
    Am J Kidney Dis; 2007 Sep; 50(3):421-32. PubMed ID: 17720521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hospitalized patients with atrial fibrillation compared to those included in recent trials on novel oral anticoagulants: a population-based study.
    Joppi R; Cinconze E; Mezzalira L; Pase D; Poggiani C; Rossi E; Pengo V;
    Eur J Intern Med; 2013 Jun; 24(4):318-23. PubMed ID: 23528931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial fibrillation and stroke prevention.
    Kakar P; Lip GY
    Expert Rev Neurother; 2006 Oct; 6(10):1523-30. PubMed ID: 17078791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial fibrillation and stroke risk prevention in real-life clinical practice.
    Tay KH; Lip GY; Lane DA
    Thromb Haemost; 2009 Mar; 101(3):415-6. PubMed ID: 19277398
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.